Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in pharmaceutical formulation products such as tablets, capsules, liquids orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments, inhalers and herbals.
Syncom Formulations (India) Limited, is an unlisted public company incorporated on 21 June, 1988. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 95.00 cr and the total paid-up capital is INR 94.00 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Vijay Shankarlal Bankda
Shareholder
|
00023027 | 26 years |
| Whole-time Director | Kedarmal Shankarlal Bankda
Shareholder
|
00023050 | 34 years |
| Whole-Time Director | Ankit Kedarmal Bankda | 02359461 | 1 years |
| Director | Ruchi Jindal | 09633465 | 4 years |
| Director | Ankit Jain | 05341403 | 3 years |
| Director | Ritesh Kumar Lunkad | 10275445 | 3 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SANTE BIOTECH PRIVATE LIMITED |
Active
|
1.0 L | 2 | Madhya Pradesh |
| SYNMEX PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 2 | Madhya Pradesh |
| VINCIT BIOTECH INTERNATIONAL PRIVATE LIMITED |
Active
|
1.0 L | 2 | Madhya Pradesh |
| ARP PHARMA PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Madhya Pradesh |
| STRAND DEVELOPERS PRIVATE LIMITED |
Active
|
1.3 Cr | 1 | Maharashtra |
| M.P. PHARMA RESEARCH AND ANALYTICAL FOUNDATION |
Active
|
30,000.0 | 1 | Madhya Pradesh |
| IRONMAN STEELS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Madhya Pradesh |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SANTE BIOTECH PRIVATE LIMITED | Madhya Pradesh | 2022 | ₹ 1.0 L |
| SYNMEX PHARMA PRIVATE LIMITED | Madhya Pradesh | 2022 | ₹ 1.0 L |
| VINCIT BIOTECH INTERNATIONAL PRIVATE LIMITED | Madhya Pradesh | 2022 | ₹ 1.0 L |
Read more
The incorporation date of SYNCOM FORMULATIONS (INDIA) LIMITED is 21 June, 1988
The authorized share capital of SYNCOM FORMULATIONS (INDIA) LIMITED is INR ₹ 95.0 Cr.
The paid-up capital of SYNCOM FORMULATIONS (INDIA) LIMITED is INR ₹ 94.0 Cr.
The registered address of SYNCOM FORMULATIONS (INDIA) LIMITED is 7, Niraj Industrial Estate, Off Mahakali Caves Road Andheri (East), Mumbai City, Mumbai, Maharashtra, India, 400093 - 400093
The CIN number of SYNCOM FORMULATIONS (INDIA) LIMITED is L24239MH1988PLC047759.